Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Jaap Verweij; PG Casali; J Zalcberg; A LeCesne; P Reichardt; JY Blay; R Issels; A van Oosterom; PCW Hogendoorn; M Glabbeke; R Bertulli; I Judson

doi:10.1016/S0140-6736(04)17098-0

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Jaap Verweij, PG Casali, J Zalcberg, A LeCesne, P Reichardt, JY Blay, R Issels, A van Oosterom, PCW Hogendoorn, M Glabbeke, R Bertulli, I Judson

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

1497 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1127-1134
Number of pages	8
Journal	Lancet (UK)
Volume	364
DOIs	https://doi.org/10.1016/S0140-6736(04)17098-0
Publication status	Published - 2004

Research programs

EMC MM-03-86-08

Access to Document

10.1016/S0140-6736(04)17098-0

http://hdl.handle.net/1765/56137

Cite this

@article{99913c950fc24b798e538a24a4f53658,

title = "Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial",

author = "Jaap Verweij and PG Casali and J Zalcberg and A LeCesne and P Reichardt and JY Blay and R Issels and {van Oosterom}, A and PCW Hogendoorn and M Glabbeke and R Bertulli and I Judson",

year = "2004",

doi = "10.1016/S0140-6736(04)17098-0",

language = "Undefined/Unknown",

volume = "364",

pages = "1127--1134",

journal = "Lancet (UK)",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

AU - Verweij, Jaap

AU - Casali, PG

AU - Zalcberg, J

AU - LeCesne, A

AU - Reichardt, P

AU - Blay, JY

AU - Issels, R

AU - van Oosterom, A

AU - Hogendoorn, PCW

AU - Glabbeke, M

AU - Bertulli, R

AU - Judson, I

PY - 2004

Y1 - 2004

U2 - 10.1016/S0140-6736(04)17098-0

DO - 10.1016/S0140-6736(04)17098-0

M3 - Article

SN - 0140-6736

VL - 364

SP - 1127

EP - 1134

JO - Lancet (UK)

JF - Lancet (UK)

ER -